Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.066 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |